/other/Diamyd_Medical_AB_publ-logo.png?Expires=1750046961&Signature=LmoGUL5tJg0EEij2zmh0mlWXfhiFJ2vkEPOiahhgIMAxM4WXl1jXInyu0ajc~QvjapfXbZ2Dws2l-7QUd-WiN4WRb-ocwZykJFDJ6zizTB4vP2noe7VwEywsM4jK9jrSdIHTJqFNUj1VTgh9AGPzDJQy53bX4SLWVenrrHded8vy3h8ceQZIwPdzvmhPBBqItBMtGJd1lD4dVWFZAKiQJQy818zipNBBNxz31XDxFZSdfbKxS1d0wwvW0-9xlnC6Q4bBN4OszlTG1yajijbpq2pvTCMfzHSry7JlbhKr1UMxUSuFkQgej5y62LM3FT6klLEJ83A-0zgyymcpnC1nlg__&Key-Pair-Id=K6QMJA61RGOXQ){kind=logo}
Diamyd Medical AB (publ)
DMYD | FN
Overview
Corporate Details
- ISIN(s):
- SE0005162872 (+5 more)
- LEI:
- 5493003NP2HNQDEKB804
- Country:
- Sweden
- Address:
- BOX 7349, 103 90 STOCKHOLM
- Website:
- N/A
- Sector:
- Health Care
- Industry:
- Biotechnology
Description
Diamyd Medical AB is a biotech company working on precision medicine for autoimmune diabetes. They are developing antigen-specific immunotherapies.
Financials & KPIs
No data available
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
Chat, Summarize & Extract with AI!
You have of free filing views remaining.
Upgrade for unlimited access.
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| No filings match the current criteria. | ||||
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
OSE Immunotherapeutics | France | OSE | |
|
Ovoca Bio Plc | Ireland | OVXA | |
|
Oxford Biomedica PLC | United Kingdom | OXB | |
|
OXFORD CANNABINOID TECHNOLOGIES HOLDINGS PLC | United Kingdom | OCTHF | |
|
Oxurion NV | Belgium | OXUR | |
|
PCI Biotech Holding | Norway | PCIB | |
|
Pentixapharm Holding AG | Germany | PTP | |
|
Perpetua Medical AB | Sweden | PERP | |
|
PharmaLundensis AB | Sweden | PHAL | |
|
Pharma Mar S.A. | Spain | PHM |